Abstract: Hair pulling disorder (HPD; trichotillomania) is thought to be associated with significant psychiatric comorbidity and functional impairment. However, few methodologically rigorous studies of HPD have been conducted, rendering such conclusions tenuous. The following study examined comorbidity and psychosocial functioning in a well-characterized sample of adults with HPD (N=85) who met DSM-IV criteria, had at least moderate hair pulling severity, and participated in a clinical trial. Results revealed that 38.8% of individuals with HPD had another current psychiatric diagnosis and 78.8% had another lifetime (present and/or past) psychiatric diagnosis. Specifically, HPD showed substantial overlap with depressive, anxiety, addictive, and other body-focused repetitive behavior disorders. The relationships between certain comorbidity patterns, hair pulling severity, current mood and anxiety symptoms, and quality of life were also examined. Results showed that current depressive symptoms were the only predictor of quality of life deficits. Implications of these findings for the conceptualization and treatment of HPD are discussed.
Introduction
Hair Pulling Disorder (HPD) is an obsessive-compulsive spectrum condition in which individuals pull hairs from their own body, resulting in significant hair loss (American Psychiatric Association, 2013) . Subclinical hair pulling is relatively common (i.e., 11%) while clinical hair pulling, or diagnosable HPD, is less frequent (Woods et al., 1996) . The lifetime prevalence rate of HPD as defined in DSM-IV-TR is estimated at about 0.6% (APA, 2000) , but may be as high as 3.4% for women and 1.5% for men (Christenson et al., 1991a and Christienson et al., 1991b) . Studies on the gender distribution of HPD suggest it is Beyond measuring specific facets of psychosocial functioning in HPD, researchers have also investigated the relationship between HPD and global indices of quality of life, with results being mixed. Keuthen et al. (2004) found no significant differences on quality of life measures between persons with HPD (N=58) and healthy controls (from published norms). In contrast, two other studies found that persons with HPD (n=28 and 70) had poorer quality of life scores than non-psychiatric controls (n=28 and 25) (Diefenbach et al., 2005b and Odlaug et al., 2010) . Three studies (Diefenbach et al., 2005b , Keuthen et al., 2004 and Tung et al., 2014 with various sample sizes (n=28, 58 and 187) found that depression severity significantly predicted quality of life, even while controlling for hair pulling severity, and a fourth study (Odlaug et al., 2010) (n=70) showed that persons with HPD who reported poor quality of life also reported higher scores on depression indices. Furthermore, in a related study examining life disability in HPD (N=153), focused hair pulling severity and pulling-related distress and interference predicted life disability while controlling for depression, but depression also correlated with life disability (Tung et al., 2015) . These results indicate that quality of life and HPD might be at least partially mediated through an association with depression.
Given the difficulties in psychosocial functioning experienced by persons with HPD, perhaps it is not surprising that HPD patients are generally believed to suffer from comorbid psychiatric disorders at a higher rate than the general population. In reviewing the HPD literature, 20 studies reported comorbidity rates in adults with HPD, but these rates varied widely from study to study. For example, rates for comorbid depressive disorders ranged from 14% to 60% (Christenson and Mansueto, 1999 , Keijsers et al., 2006 , van Minnen et al., 2003 and Odlaug et al., 2010 , anxiety disorders from 2.3% to 57% (van Minnen et al., 2003 and Christenson et al., 1991a) , and OCD from 5% to 27% (Christenson et al., 1991a and Schlosser et al., 1994) . It is unclear what factors contributed to these inconsistencies, but many of the studies reporting comorbidity rates in HPD possess methodological limitations. First, some studies used unstructured assessment instruments (e.g., Christenson et al., 1991a and Christienson et al., 1991b) or (online) self-report measures (e.g., Woods et al., 2006a) . Second, some studies reported current comorbid disorders, while others reported on lifetime comorbidity. Third, not all studies were published in peer-reviewed journals (Hand et al., 1996) . Finally, some study samples did not consist entirely of persons with HPD and failed to report statistics specifically for HPD (e.g., Grant and Christenson, 2007) .
After 4 studies with significant limitations were set aside, there remained 16 studies of sufficient methodological scrutiny that report comorbidity rates in HPD. These studies were all published in peerreviewed journals, used structured or semi-structured diagnostic assessments, used samples that clearly consisted of individuals with HPD, and provided clearly delineated results for specific diagnoses (e.g., "major depression" rather than "mood disorder"). A summary of the characteristics of these studies and their data are presented in Table 1, Table 2 and Table 3 . Visual analysis of these tables showed that comorbidity rates and study characteristics (i.e., sample sizes) for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
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still vary considerably across studies. This variability could have been caused by the fact that several diagnostic classification systems were used in these studies. Also, most studies did not report data on many comorbid disorders. Finally, these studies used a variety of recruitment practices, meaning that selection bias likely impacted comorbidity rates. 
Social phobia
Specific phobia
Eating disorder Due to the limitations of the literature on comorbidity rates in HPD, there is a need to characterize comorbidity patterns in persons with HPD using larger and well-characterized samples with psychometrically sound and rigorous assessment instruments. These results can then be compared to those of previous research in order to create better-established norms of HPD comorbidity. The current study reports on comorbidity data from a recently completed, federally funded clinical treatment trial of adults with HPD (R01MH080966; for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
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Woods, PI) that includes one of the top three largest samples of HPD collected to date. In addition to describing patterns of comorbidity, the relationship between psychiatric comorbidity and psychosocial functioning in persons with HPD are explored.
Method

Participants
Eighty-five adults with HPD participated in a randomized controlled trial comparing the relative efficacy of Acceptance-Enhanced Behavior Therapy to supportive psychotherapy. Participants were recruited via local newspaper ads, public transportation flyers, newsletters, website advertisements via the Trichotillomania Learning Center, and clinic referrals to a university-based HPD specialty clinic. The recruitment advertisements stated:
Are you an adult between the ages of 18 and 65 who pulls their hair? If you do, you may be eligible to participate in a research study. The Psychology Department at the University of Wisconsin-Milwaukee is conducting research on the effectiveness of non-drug treatments for hair pulling in adults. The study will take up to 9 months to complete, treatment is free, and participants will be paid up to $200 for their participation in the study. For more information, please call… Inclusion criteria included: (1) a current DSM-IV-TR diagnosis of HPD, based on a semi-structured clinical interview; (2) a Massachusetts General Hospital Hairpulling Scale score of ≥12; (3) a Wechsler Test of Adult Reading score of ≥85; (4) age 18-65; (5) ability to speak English fluently; (6) judged able to be maintained on outpatient status for the duration of treatment; (7) no initiation or change in the dosage of any psychotropic medication for up to eight weeks preceding participation in the study or during the course of the study; and (8) not currently receiving psychotherapy for HPD or another psychiatric condition.
Exclusionary criteria included: (1) a positive diagnosis of bipolar disorder, psychotic or neurocognitive disorder, substance dependence (with the exception of nicotine dependence), intellectual disability, or pervasive developmental disorder; and (2) a primary diagnosis of a mood or anxiety disorder. In addition, individuals who admitted ingesting hair after pulling were eligible for participation only after they had received a physical exam from their primary care physician to determine if there was any gastrointestinal blockage requiring more immediate care. One exception to exclusion criteria was made. A single individual who had experienced several periods of depression and a single hypomanic episode, thus meeting criteria for Bipolar II, was allowed to participate the study after the evaluators and principal investigator discussed the case.
Ninety-one participants (92.2% female; mean age=35.39) completed the baseline assessment battery. Most were Caucasian (82.3%), 12.9% were Black or African American, 1.2% were Asian, 1.2% were Hispanic, and 3.5% identified as Other.
Measures
The study utilized a screening questionnaire to assess many self-reported aspects of participants' demographics and psychosocial functioning. Additionally, several standardized assessment measures were used.
Diagnosis
The Structured Clinical Interview for DSM-IV Patient Version (SCID-P; First et al., 2002) was used to evaluate the presence of comorbid psychiatric disorders. The interview provides the trained rater with standardized probes about symptoms of DSM-IV disorders and provides a scoring algorithm for DSM-IV diagnosis. The SCID-P examines both lifetime (present and past) and current diagnoses. Lifetime comorbidities were given if the participant met criteria for a past and/or current diagnosis. Comorbidities assessed in this study were limited to those covered in the SCID-P, as well as HPD and skin picking. This study did not assess for Attention Deficit/Hyperactivity Disorder, sexual disorders, and personality disorders.
The Trichotillomania Diagnostic Interview (TDI; Rothbaum and Ninan, 1994) is a six-item interview that is modeled after the Structured Clinical Interview for the DSM-III-R. Although no psychometric data are available for this instrument, it offers a structured method for assessing the presence or absence of HPD, and is commonly used to diagnose HPD (e.g., Grant et al., 2009 , Tolin et al., 2007 and Diefenbach et al., 2008 .
Hair pulling severity
The Massachusetts General Hospital Hairpulling Scale (MGH-HPS; Keuthen et al., 1995 and O'Sullivan et al., 1995) is a widely used self-report severity measure of HPD consisting of two factors: "Severity" and "Resistance and Control" (Keuthen et al., 2007) . The MGH-HPS has 7 items that are scored on a 5-point Likert scale for a total ranging from 0 to 28, with higher scores reflecting greater hair pulling severity, lower resistance to pulling, and less control over pulling. It has demonstrated satisfactory psychometric properties ( Diefenbach et al., 2005a , Keuthen et al., 1995 and O'Sullivan et al., 1995 .
The National Institutes of Mental Health Trichotillomania
Severity Scale (NIMH-TSS; Swedo et al., 1989 ) is a semi-structured clinical interview that asks questions about time spent pulling, resistance to pulling urges, distress, and impairment. Possible scores range from 0 to 25. The scale has shown adequate psychometric properties for assessing HPD in both adults and children ( Diefenbach et al., 2005a , Franklin et al., 2011 , Stanley et al., 1999 and Swedo et al., 1989 .
General psychological functioning
The Quality of Life Inventory (QOLI; Frisch et al., 1992 ) is a 32-item self-report measure that assesses raters' satisfaction with 16 life areas. The reliability of the QOLI is adequate, with a temporal stability rating of 0.73 and coefficient alpha of 0.79. The measure has also demonstrated adequate convergent and discriminant validity. QOLI tscores were used in the present analyses and scored according to Frisch (1992) .
The Beck Anxiety Inventory (BAI; Beck et al., 1988b and Beck et al., 1988a) and The Beck Depression Inventory (BDI; Beck, 1972) are widely used to assess anxiety and depression, respectively. Both measures demonstrate strong psychometric properties (Fydrich, Dowdall, & Chambless, 1992; Beck et al., 1988b and Beck et al., 1988a) .
Procedure
A multi-gate assessment procedure was used to screen participants for eligibility into the study. First, patients were screened by telephone. All callers to the HPD clinic were provided information about the study and screened for possible participation. If the participant appeared to be eligible and interested, he or she was scheduled for an initial clinic screening, during which consent was obtained and inclusion/exclusion criteria checked. Participants deemed ineligible or those not wishing to participate were referred for standard clinical services. Over two hundred individuals (274) were screened via telephone. Of the 157 who were screened out at the phone stage, 30 reported having exclusionary diagnoses (24 for bipolar, 4 for schizophrenia, 1 for intellectual disability, and 1 for dementia) and were never formally assessed for HPD. Within the 117 persons who passed the phone screen and came into the clinic for the in-person screen, 21 were ineligible. Reasons included subthreshold level of hair pulling severity (n=13), lacking an HPD diagnosis (n=5), below minimum intelligence (n=1), and primary diagnosis of another mental disorder (n=2; i.e., mood disorder). Another 6 participants were lost between screening and baseline assessment due to inability to reestablish contact.
IRB approval for this project was obtained at Texas A&M University (IRB2013-3025) and the University of Wisconsin-Milwaukee (IRB09.039), and the study is publicly listed on ClinicalTrials.gov (#NCT00872742). The study was performed in compliance with the Code of Ethics of the World Medical Association (Declaration of Helsinki). Data for this manuscript were obtained from the baseline assessment of the treatment trial.
Results
Hair pulling and psychosocial functioning
The baseline sample reported moderately severe hair pulling according to both the MGH-HPS (M=16.93, SD=4.53) and NIMH-TSS (M=14.34, SD=3.64).
Comorbidity
According to the SCID-P (Table 4) , the majority of patients (78.8%) met criteria for at least one lifetime comorbid psychiatric condition, and 38.8% were determined to be currently suffering from another Axis I disorder. The most common lifetime comorbid conditions were Major Depression, Alcohol Abuse, PTSD, and GAD. The most common current comorbid conditions were Excoriation Disorder and Generalized Anxiety Disorder, followed by Specific Phobia and Obsessive-Compulsive Disorder. The most notable differences between data from this study and average current comorbidity rates from previous studies (See Table 2,  Table 3 and Table 4 ; current study data reported first) were on Excoriation Disorder (12.9% vs. 21.6%), Major Depression (3.5% vs. 17.1%), and Obsessive-Compulsive Disorder (4.7% vs. 9.3%). Additionally, notable differences for our data and the average lifetime comorbidity rates from previous studies were on Excoriation Disorders (12.9% vs. 24.2%), OCD (7.1% vs. 15.3%), Specific Phobia (2.4% vs.
12.1%), GAD (14.1% vs. 25.6%), Alcohol Abuse Disorder (17.7% vs. 8.9%), and Substance Abuse Disorder (4.7% vs. 16.8%).
Effects of comorbidity, psychosocial functioning, and hairpulling on quality of life
In order to investigate associations between comorbidity, hair pulling variables, and measures of psychosocial functioning, we conducted multiple correlational analyses comparing BAI, BDI, MGH, NIMH-TSS, and the presence of current or lifetime comorbidity to QOLI scores. A full correlation matrix is shown in Table 5 . Both Pearson and point-biserial correlations were used, and due to the propensity for multiple comparisons to increase Type I error rates, we used a Bonferroni correction to adjust alpha levels. Only BDI scores were significantly correlated with the QOLI. This suggests that, in persons with HPD, current depressive symptom severity is the best predictor of current ratings of quality of life. 
Discussion
The aims of the current study were to describe psychosocial functioning and comorbid psychopathology within a well-characterized sample of adults with HPD with moderate hair pulling severity and to investigate the relationships between these variables and quality of life.
In this study, persons with HPD reported quality of life in the upper part of the low range, which was very similar to that reported by three previous studies utilizing the same measure (Raw score means on the QOLI=41.20 vs. 43. 00, 44.31, 42.77; Diefenbach et al., 2005b and Odlaug et al., 2010; Tung, personal communication, October 4, 2015) . The findings on current levels of depressive and anxiety symptoms are not as consistent with previous findings. This study showed current depressive and anxiety symptoms to be within the minimal to mild range, along with a high degree of variance. Although these findings are consistent with that of several studies (Diefenbach et al., 2005b and Keuthen et al., 2004 , 2012 Odlaug et al., 2010) , they contrast with Woods et al. (2006a) , who reported mean depression and anxiety scores in the severe range on the Depression Anxiety Stress Scale (DASS-21; Lovibond and Lovibond, 1995) . Perhaps the Woods et al. (2006a) study, which utilized an internet sample of self-identified HPD participants, found higher rates of depressive and anxiety symptoms due to sampling differences, such that persons with HPD who participate in internet-based surveys may be more secretive and impaired than those who are willing to participate in a clinical trial.
In reviewing the literature, we found vastly differing rates of comorbidity among people diagnosed with HPD. In the current study, rates of both lifetime and current psychopathology were high, at 78.8% and 38.8%, respectively. These rates are elevated as compared to community norms, as studies have shown that, in a representative community U.S. adult sample, we should expect to find 46% lifetime and 26% twelve-month prevalence of at least one psychiatric disorder (Kessler et al., 2005b and Kessler et al., 2005a) . Specifically, this study found high rates of comorbid ExD, Generalized Anxiety Disorder, Specific Phobia, Major Depression, PTSD, as well as other anxiety and addictive disorders. One finding that has notable implications is that comorbid OCD was shown in 7.1% of individuals over their lifetime. Proponents of the OCD-spectrum, including HPD, have proposed that shared comorbidity is evidence of this relationship, yet our findings stand in contrast to such arguments. Evidence from other studies on comorbidity rates between OCD and HPD has been mixed, as expert reviews have pointed to poor evidence for high comorbidity rates (Storch et al., 2008) while the literature review conducted in the current study points to high rates of current and lifetime comorbidity.
The results from the current study and the mixed findings in the literature suggest that more research is needed on the topic.
There were several notable differences between the comorbidity rates found in the current study and those in the HPD literature. The direction of those differences was largely in the direction of lower estimates of current and lifetime comorbidity in the current study as compared to those reported in previous studies. Although the clinical trial from which these data were derived did exclude a number of individuals with comorbid diagnoses, most exclusions came because of self-reported bipolar disorder during the phone screen. Only two individuals were excluded for a primary diagnosis of severe depression. Differences in the rates of Excoriation Disorder between our study and that of Tung et al. (2015) might seem large, but a review by Snorrason et al. (2012) showed that comorbidity rates between HPD and Excoriation fall between 10% and 34% (average=20.8%). Thus, our rate of Excoriation disorder might be below average, but not outside the range of other studies. One potential reason why lower rates of mood, anxiety, and substance use disorders were found in the current study is that individuals with HPD in addition to these diagnoses may seek treatment for HPD less frequently than persons with HPD alone. While experiencing the effects of depression, anxiety, or drug addiction, individuals might view hair pulling as a relatively minor problem and be unlikely to seek HPDspecific treatment. Thus, individuals with HPD who seek treatment for HPD might be less likely to be suffering from other conditions, whereas the more complicated group of persons with HPD exist in less specialized settings. This notion could be seen as consistent with critics of the methodology of randomized clinical trials (Westen et al., 2004) , in that they tend to recruit individuals who lack treatment-complicating characteristics such as psychiatric comorbidity, making it difficult to generalize their results to real-world settings.
Although HPD is indeed associated with other psychosocial conditions, comorbid diagnoses and hair pulling symptoms do not seem to account for deficits in global functioning. Instead, it appears that current internalizing symptoms largely account for reductions in quality of life, a finding that is consistent with those of previous studies (Diefenbach et al., 2005b , Keuthen et al., 2004 , Odlaug et al., 2010 , Tung et al., 2014 and Tung et al., 2015 . It must, however, be noted that the variable correlating significantly with quality of life, depression, was measured continuously and allowed to freely vary, whereas some other variables were constrained due to inclusion criteria (i.e., MGH≥12). This practice could have attenuated the correlation between hair pulling severity as measured by the MGH. Thus, a more diverse community and clinical sample of persons with HPD and subclinical hair pulling might provide different results.
The current study has a number of implications for future research. First, future investigations should seek to understand individuals with HPD who have relatively high psychosocial functioning aside from hair pulling. Understanding factors contributing to emotional and functional resiliency in the face of moderate to severe hair pulling could have important implications for predicting outcomes and enhancing treatment. Second, results might clarify how and when selective serotonin reuptake inhibitors (SSRIs) should be prescribed for persons with HPD. Currently, SSRIs are routinely used to treat HPD (Woods et al., 2006a) despite little data supporting their effectiveness (Bloch et al., 2007 and McGuire et al., 2014) . Data from the current study suggest SSRIs may help improve QOL by reducing depressive symptoms, even if the medications do little to the pulling symptoms. However, even though it has been proposed that individuals with HPD who display comorbid mood and anxiety issues may be ideal candidates for combined behavioral and pharmacotherapy (Dougherty et al., 2006) , combined pharmacological and behavioral treatment does not always produce enhanced results, as evidenced by treatment studies for OCD (Foa et al., 2005) . Third, it is conceivable that comorbidity rates might decrease as a result of changes in HPD diagnostic criteria from DSM-IV to DSM-5. Because DSM-5 removed two criteria, this would likely result in more hair pullers receiving the HPD diagnosis. Persons with less severe hair pulling would now be diagnosed in greater numbers, and these persons would be expected to show reduced rates of comorbid anxiety and depression, which are thought to often come as a consequence of hair pulling (Diefenbach et al., 2002 , Keuthen et al., 1998 and Keuthen et al., 2001 ).
The primary limitation of this study is that potential participants were screened out for some comorbidities that might impact treatment (e.g., mania, psychosis, and primary major depression), which creates selection bias that undoubtedly affects the results of this study. A related concern is that all individuals in the current study were seeking treatment for HPD, which could result in an over-estimation of the amount of comorbidities, as these persons are more likely to seek help (Du Fort, Newman, and Bland, 1993) . Ultimately, in order to provide the best estimates of comorbidity, in a TTM community-based population, researchers would need to conduct a broad survey of the community that reduced selection bias, but HPD was left out of such efforts that have already been conducted (i.e., the National Comorbidity Study).
Other limitations to the current study include the lack of a psychiatric control group, which limits the ability to determine if these psychosocial patterns (i.e., QOL, depression, and anxiety) are specific to those with HPD. Furthermore, some additional comorbidities were not assessed, although none, other than personality disorders (Chamberlain and Odlaug, 2014) , have shown substantial comorbidity with HPD. Another potential limitation of the current study is that the QOLI may not be a highly valid measure for use in HPD. As noted by Odlaug et al. (2010) , although the QOLI assesses a range of topics including self-esteem, it contains no question regarding appearance, which can be particularly relevant for persons with HPD. Moreover, the QOLI contains no age-or gender-based norms, factors which impact quality of life (Hjermstad et al., 1998) . Thus, the QOLI norms might not accurately reflect quality of life in a sample consisting primarily of middle-aged females. These caveats notwithstanding, this study contributes substantially to the existing literature regarding comorbidity patterns in HPD. Further research attention should be directed toward comorbid and internalizing symptoms in hair pulling, which might lead to more accurate conceptualizations of HPD clinical presentation and associated impairment.
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